Albumin is one of the mainstays of treatment in some significant cirrhosis-related complications: paracentesis induced circulatory dysfunction (PICD), acute kidney injury-hepatorenal syndrome (AKI-HRS), and spontaneous bacterial peritonitis (SBP). This evidence concerns the gene ALB and acute kidney injury.